Dr Reddy's Laboratories ( RDY ) has released an update. Dr. Reddy's Laboratories has announced the satisfactory completion of a USFDA inspection at its formulations manufacturing facilities in Duvvada, Visakhapatnam, with the inspection receiving a 'Voluntary Action Indicated' status and being classified as 'closed'. This development could potentially signal a positive outlook for the company's operational compliance and reliability. For further insights into RDY stock, check out TipRanks' Stock Analysis page.